Reuben Sylvester Doggett, MD | |
305 Park Creek Dr, Clovis, CA 93611-4426 | |
(559) 326-2815 | |
(559) 326-2801 |
Full Name | Reuben Sylvester Doggett |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 305 Park Creek Dr, Clovis, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477595395 | NPI | - | NPPES |
220022684 | Other | RAILROAD MEDICARE | |
00G410350 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | G41035 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Reuben Sylvester Doggett, MD Po Box 2130, Clovis, CA 93613-2130 Ph: (559) 326-2815 | Reuben Sylvester Doggett, MD 305 Park Creek Dr, Clovis, CA 93611-4426 Ph: (559) 326-2815 |
News Archive
Oxford BioTherapeutics (OBT) today announced a strategic alliance with GlaxoSmithKline to discover, develop and commercialise novel, therapeutic antibodies for the treatment of primary, metastatic and recurring forms of cancer.
Dedicated to keeping area physicians ahead of the curve, Marquette General Health System (MGHS) will work with McKesson to deploy electronic health record (EHR) technology designed to help improve patient care throughout Michigan's Upper Peninsula. The region's only tertiary care provider plans to use McKesson's Practice PartnerĀ® EHR, which integrates with the McKesson ParagonĀ® hospital information system (HIS) currently supporting Marquette General Hospital and its 30 owned physician practices.
A study carried out by researchers from the University of Granada in collaboration with San Cecilio Clinic Hospital has scientifically proved that neonate girls present a greater antioxidant defense and less oxidative stress on their cell membranes than boys, in addition to higher antioxidant enzymatic activity.
Drugs taken by kidney transplant recipients to prevent organ rejection carry similar risks of cancer, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that no single medication is to blame for the higher incidence of cancer seen among patients who have undergone transplantation.
Delcath Systems, Inc. announced today that it has executed a multi-year supply agreement with Synerx Pharma, LLC and Bioniche Teoranta, an affiliate of Mylan, Inc., for the supply of Delcath's branded melphalan hydrochloride for injection ("melphalan"). Melphalan is the chemotherapeutic drug used with Delcath's Chemosaturation system in its Phase III clinical study for the treatment of patients with hepatic metastases from ocular or cutaneous melanoma.
› Verified 4 days ago
Baorong Chen, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 305 Park Creek Dr, Clovis, CA 93611 Phone: 559-326-2815 Fax: 559-326-2815 | |
Stevan Knezevich, Pathology Medicare: Accepting Medicare Assignments Practice Location: 305 Park Creek Dr, Clovis, CA 93611 Phone: 559-326-2800 | |
Paul H Atmajian, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 305 Park Creek Dr, Clovis, CA 93611 Phone: 559-326-2815 Fax: 559-326-2801 | |
Daniel G.k. Phillips, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 305 Park Creek Dr, Clovis, CA 93611 Phone: 559-326-2800 Fax: 559-326-2801 | |
Robert M Futoran, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 305 Park Creek Dr, Clovis, CA 93611 Phone: 559-326-2815 Fax: 559-326-2801 | |
Dr. Roberto Alvaro Allam Taguibao, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 305 Park Creek Dr, Clovis, CA 93611 Phone: 559-326-2800 Fax: 559-326-2801 | |
John Steven Pollard, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 305 Park Creek Dr, Clovis, CA 93611 Phone: 559-326-2815 Fax: 559-326-2801 |